SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-18-069927
Filing Date
2018-11-26
Accepted
2018-11-26 17:24:28
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 a18-40669_1424b5.htm 424B5 315440
2 GRAPHIC g406691bk01i001.jpg GRAPHIC 2089
3 GRAPHIC g406691hoi001.jpg GRAPHIC 2882
4 GRAPHIC g406691bi01i001.jpg GRAPHIC 2090
  Complete submission text file 0001104659-18-069927.txt   326713
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-219851 | Film No.: 181201488
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1